Treatment of Fatty Liver Disease: The Present and the Future

Non-alcoholic fatty liver disease (NAFLD) progressing to non-alcoholic steatohepatitis (NASH), cirrhosis, end-stage liver disease (ESRD), and hepatocellular carcinoma (HCC) is emerging as a global epidemic. Obesity, diabetes, and metabolic syndrome are some of the leading risk factors for NAFLD. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramanan, Sruthi Priyavadhana, Mohamed, Mohamed Wael F, Aung, Su Sandi, Sange, Ibrahim, Hamid, Pousette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7883529/
https://www.ncbi.nlm.nih.gov/pubmed/33614318
http://dx.doi.org/10.7759/cureus.12713

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7883529/
https://www.ncbi.nlm.nih.gov/pubmed/33614318
http://dx.doi.org/10.7759/cureus.12713

Ejemplares similares